Braxia Scientific Corp (BRAXF)
0.0065
0.00 (0.00%)
USD |
OTCM |
Jun 24, 16:00
Braxia Scientific Total Liabilities (Quarterly): 2.038M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.038M |
| September 30, 2023 | 1.749M |
| June 30, 2023 | 1.436M |
| March 31, 2023 | 1.685M |
| December 31, 2022 | 1.072M |
| September 30, 2022 | 2.428M |
| June 30, 2022 | 2.026M |
| March 31, 2022 | 2.140M |
| December 31, 2021 | 2.112M |
| Date | Value |
|---|---|
| September 30, 2021 | 2.004M |
| June 30, 2021 | 1.921M |
| March 31, 2021 | 2.060M |
| December 31, 2020 | 1.312M |
| September 30, 2020 | 0.8315M |
| June 30, 2020 | 0.4639M |
| March 31, 2020 | 0.0529M |
| December 31, 2019 | 0.0466M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0466M
Minimum
Dec 2019
2.428M
Maximum
Sep 2022
1.493M
Average
1.749M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.56M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.763M |
| Shareholders Equity (Quarterly) | -0.2758M |
| Debt to Equity Ratio | -0.2955 |
| Current Ratio | 0.1802 |
| Net Debt Paydown Yield | 6.85% |